Abano Healthcare (ABA) has posted an operating after tax profit of $3.4 million for the six months to the end of November.
The NZX-listed company's earnings before interest, tax, depreciation and amortisation (ebitda) were $13m, from revenue of $102.3m.
The company also made $76.6m from selling its audiology business, BayAudiology, to National Hearing Care for $157.8m, bringing its net after-tax profit to $80m. The company returned over $29.5m of what it made from the sale to its shareholders.
Abano shares paid an interim dividend of 52c each, with earnings of 344.17c per share, its unaudited results showed.
Chairwoman Alison Paterson said the company now had no New Zealand debt and ample funding to continue investing in its growth businesses - Audiology in Australia and Asia, Dental in New Zealand and Australia and Radiology in New Zealand.
"It has been a busy and pleasing first half year for Abano, particularly given the very difficult economic climate and trading conditions in New Zealand," she said.
The company owns pathology, radiography and rehabilitation facilities in New Zealand, dental chains in New Zealand and Australia and audiology businesses in Australia, Hong Kong, Singapore and Malaysia.
Shares in the company reached a year high of $7.05 last August and were last traded yesterday at $6.08.
